Lymphoma (Lymphomas) Summary

Networked: 32046 relevant articles (1985 outcomes, 3492 trials/studies) for this Disease

Key Drugs and Agents for Lymphoma

1. rituximab (Mabthera) : 204 outcomes 204 studies in 1159 results : FDA 3
   
2. Doxorubicin (Adriamycin) : 92 outcomes 91 studies in 619 results : FDA 12 Generic
   
3. Cyclophosphamide (Cytoxan) : 87 outcomes 99 studies in 690 results : FDA 10 Generic
   
4. Methotrexate (Mexate) : 80 outcomes 75 studies in 633 results : FDA 8 Generic
   
5. Vincristine (Oncovin) : 68 outcomes 87 studies in 511 results : FDA 17 Generic
   
6. Etoposide (VP 16) : 61 outcomes 91 studies in 448 results : FDA 16 Generic
   
7. Antibodies : 45 outcomes 68 studies in 818 results : IBA
   
8. Prednisone (Sone) : 44 outcomes 64 studies in 335 results : FDA 119 Generic
   
9. fludarabine : 35 outcomes 30 studies in 134 results : IBA
   
10. Antigens : 34 outcomes 97 studies in 1361 results : IBA
    

Diseases Related to Lymphoma

1. Neoplasms (Cancer)
2. Leukemia
3. Lymphoma (Lymphomas)
4. Carcinoma (Carcinomatosis)
5. Non-Hodgkin Lymphoma (Lymphosarcoma)

Key Therapies for Lymphoma

1. Drug Therapy (Chemotherapy) : 554 outcomes 463 studies in 4160 results
   
2. Radiotherapy : 121 outcomes 102 studies in 1097 results
   
3. Transplants (Transplant) : 75 outcomes 81 studies in 1127 results
   
4. Combination Drug Therapy (Combination Chemotherapy) : 72 outcomes 56 studies in 457 results
   
5. Stem Cell Transplantation : 44 outcomes 68 studies in 468 results